首页|国医大师李佃贵基于"浊毒"理论辨治慢性萎缩性胃炎癌前病变胃黏膜屏障功能障碍

国医大师李佃贵基于"浊毒"理论辨治慢性萎缩性胃炎癌前病变胃黏膜屏障功能障碍

National Master of TCM Li Diangui's Experience in Differentiating and Treating Gastric Mucosal Barrier of Precancerous Lesions in Chronic Atrophic Gastritis Based on"Turbidity-toxin"Theory

扫码查看
国医大师李佃贵以"浊毒"理论为指导,基于本病脾虚毒损胃络的病机特点,分别采用化浊解毒、补虚荣络、祛瘀通络的治法以改善或增强胃黏膜屏障功能,降低慢性萎缩性胃炎癌变率.
Under the guidance of"turbidity toxin"theory,based on the pathogenesis of spleen deficiency and toxin damaged stomach collateral,national master of TCM Li Diangui adopted resolving turbidity and detoxifying,tonifying the deficiency and nourishing the collateral,removing stasis and dredging the collateral respectively to improve or enhance gastric mucosal barrier function and reduce the rate of carcinogenesis of chronic atrophic gastritis(CAG).

chronic atrophic gastritisturbidity toxinprecancerous lesionsgastric mucosal barrier

张慧、姜璐、陈俊生、张云松、李佃贵

展开 >

山东中医药大学,山东 济南 250014

济南市中医医院,山东 济南 250014

山东中医药大学附属医院,山东 济南 250014

萎缩性胃炎 浊毒 癌前病变 胃黏膜屏障

国家中医药管理局第六批全国老中医药专家学术经验继承项目(2018-2019)山东省中医药管理局齐鲁医派中医药特色技术推广项目

2024

西部中医药
甘肃中医药研究院

西部中医药

CSTPCD
影响因子:0.98
ISSN:1004-6852
年,卷(期):2024.37(8)
  • 18